New York OTC Drugmaker Scolded for Missing Lab Studies, GMP Training

Drug Industry Daily
A A
The FDA cited Advance Pharmaceutical in a Form 483 for problems with verification and training at its Holtsville, New York facility.

To View This Article:

Login

Subscribe To Drug Industry Daily